|4May 23, 5:31 PM ET

Bacopoulos Nicholas G 4

4 · Cyclacel Pharmaceuticals, Inc. · Filed May 23, 2013

Insider Transaction Report

Form 4
Period: 2013-05-22
Transactions
  • Award

    Option

    2013-05-22+3,5713,571 total
    Exercise: $2.99Exp: 2023-05-22Common Stock (3,571 underlying)
Footnotes (2)
  • [F1]These options are exercisable over a four-year period with 1/48 of the options granted vesting on a monthly basis.
  • [F2]These options were granted to Dr. Bacopoulos for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.

Documents

1 file
  • 4
    a4.xmlPrimary

    4